Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biocryst Pharmaceuticals

8.76
-0.1200-1.35%
Post-market: 8.800.0400+0.46%17:36 EDT
Volume:2.42M
Turnover:21.15M
Market Cap:1.83B
PE:-33.76
High:8.87
Open:8.87
Low:8.69
Close:8.88
Loading ...

Barclays Sticks to Its Hold Rating for BioCryst (BCRX)

TIPRANKS
·
07 May

Evercore ISI Keeps Their Buy Rating on BioCryst (BCRX)

TIPRANKS
·
07 May

Stock Track | BioCryst Pharmaceuticals Plummets 5.08% Following $30 Million Loan Prepayment

Stock Track
·
07 May

J.P. Morgan Remains a Buy on BioCryst (BCRX)

TIPRANKS
·
06 May

RBC Raises Price Target on BioCryst Pharmaceuticals to $13 From $11, Keeps Outperform Rating

MT Newswires Live
·
06 May

BioCryst Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
06 May

BioCryst Pharmaceuticals Inc : Bofa Global Research Raises Price Objective to $13 From $11

THOMSON REUTERS
·
06 May

BioCryst Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
06 May

BioCryst Pharmaceuticals Soars 23% In One Session - Here's Why It Surprised Investors

Benzinga
·
06 May

Top Midday Gainers

MT Newswires Live
·
06 May

BUZZ-U.S. STOCKS ON THE MOVE-Airline stocks, Wendy's, Skechers

Reuters
·
05 May

BioCryst Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
05 May

BUZZ-U.S. STOCKS ON THE MOVE-Stardust Power, Peabody, On Semiconductor

Reuters
·
05 May

BioCryst Pharmaceuticals (BCRX) Reports Break-Even Earnings for Q1

Zacks
·
05 May

BUZZ-BioCryst Pharma rises after lifting annual sales forecast for skin disease drug

Reuters
·
05 May

BioCryst Rises on Strong Sales of Rare-Disease Drug

Dow Jones
·
05 May

BioCryst Pharmaceuticals Shares up 13.7% Premarket After Q1 Results Beat

THOMSON REUTERS
·
05 May

BioCryst Pharmaceuticals Reports Breakeven in Q1, Higher Revenue; Shares up Pre-Bell

MT Newswires Live
·
05 May

GUIDANCE: (BCRX) BioCryst Pharmaceuticals Expects 2025 Revenue Range $580M - $600M, vs. FactSet Est of $563.6M

MT Newswires Live
·
05 May

BioCryst Pharma Q1 Sales $145.53M Beat $126.87M Estimate

Benzinga
·
05 May